T2 Biosystems, Inc.

NASDAQ:TTOO

0.345 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Revenue 7.19322.30528.05818.138.33510.54.6664.082.8130.1190.2660.019
Cost of Revenue 15.36321.13920.70321.2816.76315.40412.0286.8721.7419.78214.93611.727
Gross Profit -8.171.1667.355-3.15-8.428-4.904-7.362-2.7921.073-19.663-14.67-11.708
Gross Profit Ratio -1.1360.0520.262-0.174-1.011-0.467-1.578-0.6840.381-165.235-55.15-616.211
Reseach & Development Expenses 14.15325.93221.80116.91916.32614.48923.73324.00925.36219.78214.93611.727
General & Administrative Expenses 030.64400025.69722.75724.07719.09411.01800
Selling & Marketing Expenses 00.10000000000
SG&A 24.8330.74428.52721.28727.30425.69722.75724.07719.09411.0185.0222.945
Other Expenses 2.5110.0310.2060.0620.40.6190.3310.1720.060.012-0.5150.352
Operating Expenses 41.49456.67650.32838.20643.6340.18646.4948.08644.45630.819.95814.672
Operating Income -49.664-55.51-42.973-41.356-52.058-45.09-53.852-50.878-43.383-30.681-19.692-14.653
Operating Income Ratio -6.904-2.489-1.532-2.281-6.246-4.294-11.541-12.47-15.422-257.824-74.03-771.211
Total Other Income Expenses Net -0.413-6.807-6.268-5.442-6.948-6.063-8.576-3.926-1.907-0.709-0.9180.198
Income Before Tax -50.077-62.317-49.241-46.798-59.006-51.153-62.428-54.804-45.29-31.39-20.61-14.455
Income Before Tax Ratio -6.962-2.794-1.755-2.581-7.079-4.872-13.379-13.432-16.1-263.782-77.481-760.789
Income Tax Expense 01.0534.2542.414.1060.6199.2381.990.5620.042-0.1120.506
Net Income -50.077-63.37-53.495-49.208-63.112-51.153-62.428-54.804-45.29-31.39-20.61-14.455
Net Income Ratio -6.962-2.841-1.907-2.714-7.572-4.872-13.379-13.432-16.1-263.782-77.481-760.789
EPS -19.19-1,242.48-1,683.72-2,027.86-6,934.2-126.12-194.29-210.66-220.91-361.85-1,476.89-103.27
EPS Diluted -19.19-1,242.48-1,683.72-2,027.86-6,934.2-126.12-194.29-210.66-220.91-361.85-1,476.89-103.27
EBITDA -43.875-55.196-41.127-38.487-48.299-41.958-50.581-48.426-41.858-29.978-19.623-13.73
EBITDA Ratio -6.1-2.487-1.52-2.278-6.198-4.235-10.84-12.428-15.401-257.723-73.771-722.632